Focusing on patients needs
YD Pharmaceuticals is an innovated pharmaceutical company headquartered
in Porto, Portugal, with a strategic GMP-certified indoor cultivation facility.

At YD Pharmaceuticals, our dedication lies in ensuring that the complete therapeutic potential of medical cannabis is harnessed for the betterment of patients worldwide.

Through our profound scientific knowledge and cutting-edge methodologies, we develop innovative therapies that effectively harness the healing capabilities of the cannabis plant, offering relief for individuals grappling with chronic and debilitating conditions.

Transforming Vision into Tangible Achievements

Our unwavering commitment to a clear vision is exemplified in how we envision groundbreaking pharmaceutical products originating from cannabis and transform them into reality.

Our team of proficient experts meticulously formulate the most efficient active components to optimize bioavailability, ensuring swift and precise relief for particular conditions.

Additionally, our inventive drug delivery methods guarantee broad availability of our product range.

Through collaboration with prominent clinical experts and researchers specializing in diverse therapy areas, we aspire to develop customized, highly effective products that address currently unmet clinical needs, all driven by our forward-thinking approach.

Pioneering Progress through Expertise

In an industry marked by constant growth and evolution, our extensive knowledge, experience, and skillset position us as proficient navigators of the ever-changing European and global markets, enabling us to meet their demands effectively.

This expertise is evident in the strategic location of our manufacturing facility, allowing YD Pharmaceuticals to secure national-level marketing authorization for our cannabis-based products in Portugal. This authorization involves rigorous assessments of safety, effectiveness, and quality, assuring regulatory bodies in other countries that YD products adhere to the most stringent EU medicinal and pharmaceutical standards.

 

Elevating Industry Norms

Our unparalleled proficiency empowers us to excel in every facet of the formulation development and manufacturing journey, resulting in innovative medical cannabis therapies that exhibit the stability and uniformity one anticipates from a premier biotechnology expert.

Through our comprehensive research and development initiatives, along with rigorous testing protocols, we are reshaping perspectives and establishing fresh benchmarks within the industry, thanks to our distinctive therapeutic solutions.

Trusted Excellence in Unyielding Quality

We meticulously craft all our cannabinoid-infused products in full compliance with the stringent Good Manufacturing Practice (GMP) standards for pharmaceuticals. These products undergo stringent quality assurance evaluations, affirming their adherence to the most exacting pharmaceutical norms. Our exacting manufacturing process upholds the utmost quality and consistency of our products without compromise, consistently delivering on trust.

Enabling Patients to Prioritize Life Beyond Illness

At YD Pharmaceuticals, our patients are central to our mission, and comprehending their needs holds paramount significance. We take great pride in providing customized, groundbreaking solutions that bring about tangible improvements and enhance the overall quality of life.